Patents by Inventor Matthew Kaeberlein

Matthew Kaeberlein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of aging genes through large-scale analysis
    Publication number: 20070196850
    Abstract: High throughput methods for screening genetic variants that are phenotypically distinguishable are provided. Methods for identifying “long-lived” genetic variants among a set of variants are also provided. Methods for identifying pharmaceutical compounds that can promote longevity in various subjects, including mammals, and that can delay the onset of various diseases associated with aging are also provided. Various vectors and host cells containing identified genes/gene products are useful for screening longevity-promoting compounds that can interact with life-span-regulating genes/gene products. Pharmaceutical compositions that can promote longevity are also provided.
    Type: Application
    Filed: January 29, 2007
    Publication date: August 23, 2007
    Applicant: University of Washington
    Inventors: Brian Kennedy, Matthew Kaeberlein
  • Methods of screening and compositions for life span modulators
    Publication number: 20060234250
    Abstract: Identification of nucleic acids involved in life span diseases and disorders or related diseases and disorders, and the use of such methods for identifying candidate agents which modulate life span diseases and disorders or related diseases and disorders are provided. Compositions and methods for treating life span diseases and disorders or related diseases and disorders are provided.
    Type: Application
    Filed: April 15, 2005
    Publication date: October 19, 2006
    Inventors: Ralph Powers, Matthew Kaeberlein, Stanley Fields
  • Identification of aging genes through large-scale analysis
    Publication number: 20060068414
    Abstract: High throughput methods for screening genetic variants that are phenotypically distinguishable are provided. Methods for identifying “long-lived” genetic variants among a set of variants are also provided. Methods for identifying pharmaceutical compounds that can promote longevity in various subjects, including mammals, and that can delay the onset of various diseases associated with aging are also provided. Various vectors and host cells containing identified genes/gene products are useful for screening longevity-promoting compounds that can interact with life-span-regulating genes/gene products. Pharmaceutical compositions that can promote longevity are also provided.
    Type: Application
    Filed: April 15, 2005
    Publication date: March 30, 2006
    Inventors: Brian Kennedy, Matthew Kaeberlein